Friday, October 7, 2022

Dawn Ireland, WRAP Co-Founder, to speak at BioTechX 2022


Worldwide Rare Advocacy Partnership (WRAP) and CDH International is proud to team up with Terrapinn for the BioTechX 2022 congress to bring the Patient voice to the largest BioData event in Europe!

If your company supports the Patient Voice at medical events, email dawn.ireland@cdhi.org to learn how you can lead your industry into a new era where every stakeholder is welcome to sit at the table of Patient Care.

https://lnkd.in/gdJEXWQy

#patientadvocacy #patientadvocate #raredisease #rarediseases #biodata #biotech #patientdata #cdhinternational #congenitaldiaphragmatichernia

Tuesday, May 10, 2022

Patient Advocacy at BioTechX 2022

WRAP is proud to be an organizing sponsor Patient Advocacy at BioTechX 2022. Join us as we support the patient voice at Europe's largest BioTech event! 




Current Speakers for this section are:

  • Dr Wendy Chung - Columbia University CARES for Kids, DHREAMS, KidsFirst Database
  • Dr Dick Tibboel - Erasmus MC, ICU
  • Dr. Augusto Zani - Zani Lab, University of Toronto
  • Dawn Ireland - Founder of CDH International, Patient Registry creator, global Patient Advocate working in 84 countries 
  • Luke Rosen - Founder of KIF1A.ORG, a nonprofit organization working to rapidly discover treatment for KIF1A Associated Neurological Disorder. Senior Vice President, Accelerated Development & Community Engagement at Ovid Therapeutics.
  • Caryl Harris - Co-Founder & Executive Director, Avery's Hope, Patient Ambassador for Illumina, Former member of Rare Advocacy Movement
  • Terri Ellsworth - Professional Rare Disease KOL, Patient Advocate Thought Leader, Consultant,  Public Speaker
  • Sean Gordon - "After being diagnosed with an adult onset rare disease, I have founded www.rarefundingteam.com bringing together communications professionals and rare disease organizations on a pro bono basis. I bring over two decades of experience in sales & marketing of technology products."
  • Dr Neena Nizer Executive Director of The Jansen's Foundation. Patient and mother to two superheroes with Jansen's Metaphyseal Chondrodysplasia. Working on a cure for JMC.
  • Taylor Kane Community Engagement Manager at AllStripes, Founder and Executive Director at Remember The Girls, Rare disease speaker, advocate, consultant, and author
  • David Rose - Business Development at Rare Revolution Magazine. Ultra-Rare Disease Patient Speaker. Trustee for Mitrofanoff Support.
  • Marni B. Cartelli Patient, Advocate, Danny’s Dose Alliance
  • Meghan Rauen LCMHCA/NCC Founder and President, Global Gastroschisis Foundation. " I have extensive education and research in the medical communications, counseling, trauma, religion and medicine, patient communications, and bioethics/medical ethics."
  • Eden Lord Founder & CEO at The Dash Alliance, Creator of the first virtual rare disease events, "The Rare Fair", "24 Hours of Rare" & "Rare 72", a collaborative model for rare disease solutions. Rare Disease Mom & Patient
  • Jeff Lord - Chief Technology Officer (CTO) My City Med, rare disease dad
  • Monica Weldon - Son 1 of 6 diagnosed globally in 2012  with SYNGAP1, rare disease advocate, Founder, Biotech Investor @syngap1_Fnd VAMO contributor @pharmaboardroom
  • Onno Faber - TedEx speaker, scientist, CEO Rarebase, Founder of AllStripes, entrepreneur, keynote speaker, author, patient advocate, angel investor
  • Jason Miller - Patient Registry Administrator, CDH International
  • Carolyn Dumond - Associate Director, Global Patient Advocacy at Illumina
  • Carie Chester  - Lead Manager, Exam Operations & ServicesLead Manager, Exam Operations & Services AICPA
  • Thomas Hach, Executive Director, Patient Engagement Cardiovascular, Renal & Metabolism, Novartis  
  • Bradlay Pryde, COO, One Three Biotech 


If you are interested in speaking, please email us.

Tuesday, April 12, 2022

Legislation to Help Diagnose Children with Rare Diseases

The Ending the Diagnostic Odyssey Act would help provide relief to children and their parents by allowing states to conduct Whole Genome Sequencing (WGS) services for children on Medicaid with a disease suspected to have a genetic cause. The average diagnostic odyssey is 7-8 years. That's too long. Please learn about this and let your representatives and senators know that you support this very important piece of legislation.



Learn more!

Click here to read the text of the bill.



Tuesday, March 22, 2022

FOR IMMEDIATE RELEASE: BioTechX 2022 Congress Implements New Patient Advocacy Initiative

FOR IMMEDIATE RELEASE: 

BioData 2022 Congress Implements New Patient Advocacy Initiative 

 

London, United Kingdom / Basel, Switzerland  Tuesday, March 22, 2022 –  Patient advocates and rare disease nonprofits are overjoyed that the medical conference organizer, Terrapinn, has created a new platform to include patient voices. 


This November, BioData World Congress returns to Basel along with three co-located events. We are so excited to announce that this year BioData World Congress will take place alongside Genomics Live, PharmAI, and Cheminformatics Live. This is Europe's largest conference covering big data in pharmaceutical development and healthcare and will bring together thousands of industry leaders” announces Terrapinn on the company’s call for speakers. 


Dawn Ireland attended her first Terrapinn event at the World Orphan Drug Congress in 2017 in Washington DC.  “I was so impressed that this company was so inclusive of patients and patient advocates.  Most industry events forget that patients are the consumers and should be the focus of all events.  Right away, I knew that I would be attending a lot of Terrapinn organized events” said Ireland, who is a patient advocate and president of CDH International, a global charity for Congenital Diaphragmatic Hernia patient support and research.  


Ireland began speaking, chairing, and representing patients at Terrapinn’s BioData conference in Basel, Switzerland and World Evidence, Pricing and Access (EPA) Congress in Amsterdam.  In March of 2021, she secured a block of time for patient advocates at the EPA’s virtual event by tapping into her network of other advocates and her relationship with the Terrapinn team. 


In November of 2021, the BioData Congress was back to an in-person event and had a great attendance but there was a lack of patient advocates.   She went to Chris Shanks, head of the EPA event and admin of the BioData, and asked for another block for patient advocates.   Shanks agreed and gave Ireland 3 hours.   


Ireland took the project to the Worldwide Rare Advocacy Partnership (WRAP), a new collaboration she co-founded with 4 fellow patient advocates.   By the time the next meeting with Terrapinn was held, there were 15 well-known, well-respected patient advocates who were signed up to roll up their sleeves and bring Patient Advocacy to Terrapinn events in Europe. 


Sharing the rare patient voice at an international medical conference is so important to our patient groups. Patients and patient families want to be so much more than a number on a laboratory slide or a name on a registry. They want to be a real live human representation, not just their disease,” says Caryl Harris, co-founding partner at WRAP and Executive Director of Avery’s Hope, a patient assistance organization for the rare pediatric GI patient community. 


Shanks responded by giving Ireland the WRAP team 3 days instead of 3 hours, and Terrapinn became the first company to officially incorporate an equal presence of Patient Advocacy at a medical industry event. 


“Usually, medical conferences will give advocates and charities a discounted vendor booth, a few opportunities to speak at round tables or panels but Terrapinn has always shown Patient Advocacy as much respect as they show big Pharma and other Industry players.  They treat us as equals and that’s how every medical conference should be.  We are so grateful to them for leading the way in this important cause” says Ireland. 


“Being able to share the human side to medical data gives researchers and medical teams an opportunity to see disorders and disease from a fully human perspective,” says Harris. 


“I'm thrilled to finally see a conference organizer include the patient advocate voice on such a large scale. It's long overdue and perhaps the most important voice to hear. Thank you, Terrapin” says Terri Ellsworth, KOL Rare Disease Patient Advocate and the 3rd of 5 WRAP Co-Founding Partners. 


Ireland and her partners at WRAP are looking for more Patient Advocacy leaders to speak on BioData, as well as corporate sponsors to cover their costs to attend the event.  You can reach out to her at dawn.ireland@cdhi.org to participate.  


BioData will take place on November 8-10th at the Basel Conference Center in Switzerland. 


Contact: 
Dawn Ireland 
dawn.ireland@cdhi.org 
152 S White St 
Wake Forest, NC 27587 
(919) 610-0129 
 
###